Chargement en cours...
The Fraction Exhaled Nitric Oxide as a Biomarker of Asthma Control
INTRODUCTION AND OBJECTIVE: The main goal of asthma treatment is to achieve and maintain clinical control of the disease. The exhaled fraction nitric oxide (FeNO) level is a biomarker of T-helper cell type 2 (Th2) inflammation of the airways. Our objective was to determine whether the FeNO level can...
Enregistré dans:
| Publié dans: | Biomark Insights |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6357290/ https://ncbi.nlm.nih.gov/pubmed/30728712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1177271919826550 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|